Publication: Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Taş-Aygar, Gamze
Gönül, Muzeyyen
Özcan, İbrahim
Ayli, Mehmet Deniz
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.
Source
Publisher
Wiley
Subject
Citation
item.page.haspartof
Source
Dermatologic Therapy
item.page.ispartofseries
item.page.edition
DOI
10.1111/dth.14205
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A